Author: Caspian Fothergill
PET-CT, MRI, and PET-MRI each play unique roles in cancer staging. PET-CT finds spread, MRI shows soft tissue detail, and PET-MRI combines both for complex cases. Learn which scan is best for your cancer type.
Statins can cause temporary memory issues in some people, but long-term studies show they lower dementia risk. Learn what really causes brain fog, which statins are safest, and what to do if you're concerned.
Intentional overdose is a leading method of suicide in the U.S., especially among teens and middle-aged adults. Learn how crisis resources like 988, Crisis Text Line, and community programs are saving lives-and why funding cuts could undo years of progress.
Sedating medications are a leading cause of falls in older adults. Learn proven strategies - from medication reviews to exercise - that can cut fall risk by over 30% and save lives.
Health disparities in medication safety are not accidental - they’re systemic. Marginalized communities face higher risks of harmful drug errors due to bias, language barriers, and unequal access. Fixing this requires real data, inclusive research, and systemic change.
As we age, liver and kidney changes alter how drugs are processed - leading to higher risks of side effects and hospitalizations. Learn how these changes affect common medications and what you can do to stay safe.
Weight gain is a common side effect of many antidepressants, affecting over half of long-term users. Learn which drugs cause the most gain, why it happens, and how to manage it without quitting your medication.
Fentanyl patches deliver powerful pain relief but carry serious risks of overdose and dangerous withdrawal. Learn the warning signs, safety rules, and what to do if something goes wrong.
NTI drugs like levothyroxine and tacrolimus have a tiny window between effective and toxic doses. Switching between generic manufacturers can pose real risks-even when FDA-approved. Here’s what you need to know.
After the first generic enters the market, competition explodes - and prices crash. But with each new entrant, manufacturing strain, shortages, and consolidation follow. How the Hatch-Waxman Act shapes drug pricing and why the system is breaking down.